News stories about Arcadia Biosciences (NASDAQ:RKDA) have been trending somewhat positive on Monday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Arcadia Biosciences earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.9070772541697 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have effected Accern Sentiment’s rankings:
- Arcadia Biosciences’ GoodWheat product could be on supermarket shelves this year (bizjournals.com)
- Edited Transcript of RKDA earnings conference call or presentation 20-Mar-18 8:30pm GMT (finance.yahoo.com)
- Arcadia Biosciences Inc (RKDA) Announces the Appointment of Sarah Reiter as Chief Commercial Officer (smarteranalyst.com)
- Arcadia Biosciences, Inc. to Host Earnings Call (finance.yahoo.com)
- Arcadia raising $10 million in private offering, launching 'GoodWheat' brand products (finance.yahoo.com)
Separately, Piper Jaffray set a $20.00 price target on Arcadia Biosciences and gave the stock a “hold” rating in a research report on Wednesday, March 14th.
In other Arcadia Biosciences news, Director Eric J. Rey sold 21,255 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $45.38, for a total transaction of $964,551.90. Following the completion of the transaction, the director now owns 28,340 shares in the company, valued at approximately $1,286,069.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 27.20% of the company’s stock.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.